Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weimar

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical Transplantation|December 12, 2001
Immunosuppression should be stopped in patients with renal allograft failureP J Smak Gregoor, R Zietse, J L van Saase, et al.
Clinical Transplantation|June 27, 1998
Increased intragraft IL-15 mRNA expression after liver transplantationC C Baan, H G Niesters, H J Metselaar, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Transplant Immunology|May 3, 2003
Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantationC T J Holweg, A M A Peeters, A H M M Balk, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Lancet (London, England)|May 12, 1990
Recovery of failing liver after auxiliary heterotopic transplantationH J Metselaar, E J Hesselink, S de Rave, et al.
Stem Cells and Development|September 6, 2007
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacitiesM J Hoogduijn, M J Crop, A M A Peeters, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 14, 2015
Mental health among living kidney donors: a prospective comparison with matched controls from the general populationL Timmerman, M Laging, G J Westerhof, et al.
Transplantation|August 10, 1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantationT van Gelder, L B Hilbrands, Y Vanrenterghem, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical Transplantation|December 12, 2001
Immunosuppression should be stopped in patients with renal allograft failureP J Smak Gregoor, R Zietse, J L van Saase, et al.
Clinical Transplantation|June 27, 1998
Increased intragraft IL-15 mRNA expression after liver transplantationC C Baan, H G Niesters, H J Metselaar, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Transplant Immunology|May 3, 2003
Recipient gene polymorphisms in the Th-1 cytokines IL-2 and IFN-gamma in relation to acute rejection and graft vascular disease after clinical heart transplantationC T J Holweg, A M A Peeters, A H M M Balk, et al.
Transplantation Proceedings|November 15, 2002
Anti-CD25 therapy impairs donor-specific Th1 and Th2 cytokine-producing peripheral blood cells after clinical heart transplantationN M van Besouw, A H M M Balk, M van Vliet, et al.
Lancet (London, England)|May 12, 1990
Recovery of failing liver after auxiliary heterotopic transplantationH J Metselaar, E J Hesselink, S de Rave, et al.
Stem Cells and Development|September 6, 2007
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacitiesM J Hoogduijn, M J Crop, A M A Peeters, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 14, 2015
Mental health among living kidney donors: a prospective comparison with matched controls from the general populationL Timmerman, M Laging, G J Westerhof, et al.
Transplantation|August 10, 1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantationT van Gelder, L B Hilbrands, Y Vanrenterghem, et al.
Pageof 44